Animal health impacted by climate change

Written by IFAH-Europe on 2 December 2015 in Press Release
Press Release

Brussels, 2 December 2015 - With global heads of state meeting civil society representatives and UN agencies in Paris to discuss climate change at the COP21 event (30 November - 11 December), the animal health industry in Europe highlights the impact of climate change on animal disease and the need for innovation in veterinary medicines.

Brussels, 2 December 2015 - With global heads of state meeting civil society representatives and UN agencies in Paris to discuss climate change at the COP21 event (30 November - 11 December), the animal health industry in Europe highlights the impact of climate change on animal disease and the need for innovation in veterinary medicines.

"With temperatures becoming more clement across the continent we are seeing incidences of animal diseases in Europe that were not previously reported such as the introduction of Schmallenberg virus in 2011 from Africa or the threat of Rift Valley Fever moving into Europe. Climate change and activity such as the creation of wetlands to offset impacts may increase the presence of vectors such as ticks, mosquitoes and fleas, increasing the threat of transmissible diseases", said Roxane Feller, IFAH-Europe Secretary General.

Many vector-borne diseases1 currently lack effective medicines for treatment and prevention. Vaccination has the potential to be one of the most effective methods in dealing with these diseases, but investment in this area is often constrained by the huge costs and resources needed for research which is currently not offered adequate data protection.

Animal health companies are dedicated to bringing new veterinary medicines to market, a highly costly process (up to €129m) that can take between 5 to 11 years to complete. IFAH-Europe calls for incentives for companies to expand the range of medicines available and to develop innovative solutions for animal disease prevention and treatment.

Climate change affects us all, and it may lead to Europe seeing more diseases - new to both us and our animals - than ever before. We need innovation and vaccine banks to be ready to deal with these.

 

About the author

IFAH-Europe is the representative body of manufacturers of veterinary medicines, vaccines and other animal health products in Europe. It promotes a single market in veterinary medicines across the EU ensuring the availability of medicines to protect the health and welfare of animals. For further information on IFAH-Europe, please visit www.ifaheurope.org.

1 - Vector-borne diseases are infections transmitted by the bite of infected insect species, such as mosquitoes, ticks, triatomine bugs, sandflies, and blackflies. They are cold-blooded and thus especially sensitive to climatic factors.

 

For further press information please contact

Kim Hardie, Communications Director
Tel.: +32 2 543 75 75
E-mail: k.hardie@ifahsec.org

 

 

Share this page

Tags

Categories

Partner content

This content is published by the Parliament Magazine on behalf of our partners.

Related Articles

New EU novel food regulation comes into force
4 January 2018

The European Union’s new regulation on novel food has formally come into force.

Related Partner Content

How the animal health industry takes action on One Health
6 November 2017

One Health, is more than just a buzzword, argues AnimalhealthEurope’s Roxane Feller

PM+: EU urged to implement action plan on illegal wildlife trade
22 April 2015

The Born Free Foundation's Will Travers argues that EU policymakers must move quickly to stem the tide of the growing global trade in wildlife trafficking.

PM+: Veterinary medicines review must put investment in innovation first
19 May 2015

Current EU veterinary medicines review lacks focus on ROI for innovative companies, argues IFAH-Europe's Rick Clayton.